Neil Thompson. Picture: Healx

Neil Thompson appointed CSO of Healx

Healx, a Cambridge, UK, technology company developing treatments for rare diseases, today announces the appointment of Dr Neil Thompson, PhD, as Chief Scientific Officer (CSO).

Neil will spearhead the expansion of the drug discovery and development team at Healx.N eil brings over 30 years of experience in the biotech and pharmaceutical industries and has a background working across a breadth of disease areas. Across his three-decades-long career, he has been involved in progressing more than 10 drugs into patients and has led a number of drug discovery projects across a variety of therapeutic areas.

Commenting on his appointment, Dr Neil Thompson, CSO of Healx, said: “Healx’s novel approach of using AI to start with the patient as opposed to a target, is what first drew me to the company. I am excited to bring my experience to this leading AI-powered biotech that is helping patients with rare diseases. I am tremendously proud of the accomplishments to date, notably those I made during my time at Astex, and look forward to drawing on those experiences to build a team of dynamic, forward-thinking scientists, as we work to achieve our goal of progressing treatments to the clinic that can make a real difference to lives of patients.”